Maintenance Versus Intermittent Strategies in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis from Another Angle
Authors:
- 20 August 2019
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 36 (10) , 2838-2848
Abstract
Considering the differences in overall survival (OS) and progression-free survival (PFS), treatment options for metastatic colorectal cancer (mCRC) are still inconclusive. We carried out a meta-analysis of maintenance and intermittent strategies for the treatment of mCRC aiming at providing an accurate estimation of different treatments in increasing the chance and duration of survival.Keywords
Funding Information
- Beijing Hope Run Special Fund of Cancer Foundation of China (LC2016W02)
- Medical Scientific Research Project of Chongqing Municipal Health and Family planning commission (2015ZDXM040)
- Chongqing Natural Science Foundation (cstc2018jcyjAX0772)
This publication has 25 references indexed in Scilit:
- Seeing the forest through the trees: A systematic review of the safety and efficacy of combination chemotherapies used in the treatment of metastatic colorectal cancerCritical Reviews in Oncology/Hematology, 2014
- Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group TrialOncology, 2013
- Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 StudyJournal of Clinical Oncology, 2009
- Colorectal CancerMayo Clinic Proceedings, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Interrater Reliability of the Modified Jadad Quality Scale for Systematic Reviews of Alzheimer’s Disease Drug TrialsDementia and Geriatric Cognitive Disorders, 2001
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- Analysis of data from multiclinic trialsControlled Clinical Trials, 1986
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986